New York Attorney Applauds Mesothelioma Research Breakthrough
Attorney Joseph W. Belluck applauded news that an investigational vaccine created by researchers in the Netherlands may be able to use matter from mesothelioma tumors to provoke the immune system into generating antibodies to fight the mesothelioma cells. This vaccine has proven to be safe in studies to date.
Belluck, of Belluck & Fox, a New York law firm that advocates for victims of the asbestos-related disease mesothelioma, welcomes rare good news in efforts to cure the cancer also referred to as asbestos cancer.
Mesothelioma is a rare, aggressive cancer primarily caused by exposure to airborne asbestos fibers. Symptoms of mesothelioma may not appear until up to 50 years after initial exposure to asbestos. However, after symptoms become apparent, mesothelioma may rapidly progress to cause life-threatening complications.
The findings could lead to a vaccine that would protect people at risk from getting mesothelioma. Belluck believes this development is great news for those battling mesothelioma. “We have seen the toll of this disease and share the desire of its victims and their families to see it defeated,” said Belluck.
One of the researchers, Dr. Joachim Aerts, a pulmonary physician at Erasmus Medical Center, was quoted by Business Week as saying, “We hope that by further development of our method it will be possible to increase survival in patients with mesothelioma and eventually vaccinate persons who have been in contact with asbestos to prevent them from getting asbestos-related diseases.”